Skip to content
Merito
← Back to results
EB-2 NIWBiotech and pharmaIndividualDecided February 2025Dismissed

Outcome: Dismissed

FEB072025_02B5203

Merit and national importanceNot metWell positionedNot reached / not discussedBalance favors a waiverNot reached / not discussed

Our summary

Pharmaceutical sales representative with advanced degree seeks EB-2 national interest waiver for health-related project. Petitioner claimed national importance through health and economic benefits. AAO held substantial merit shown but national importance unmet; endeavor lacks evidence of broader field or regional impact exceeding specific occupational role.

Official PDF

Official PDF ↗

Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.

No criterion in the table was found met in this decision.

What was missing

  • Merit and national importance · Substantial merit established but national importance not demonstrated; proposed endeavor lacks evidence of broader field impact or substantial economic effects.

Criteria

CriterionReadingWhy
Merit and national importanceNot metSubstantial merit established but national importance not demonstrated; proposed endeavor lacks evidence of broader field impact or substantial economic effects.
Well positionedNot reached / not discussedFirst prong failed; second prong not reached under Dhanasar framework.
Balance favors a waiverNot reached / not discussedFirst prong failed; third prong not reached under Dhanasar framework.

A published decision describes one case. It is not legal advice and not a prediction for yours.

Similar decisions

Decisions whose text is closest to this one.